Epidemiology of Impaired Coagulant Balance in Diabetes
To determine the nature, extent and molecular mechanisms responsible for impaired fibrinolysis in White, Black, Hispanic and American Indian populations with respect to the presence or absence of diabetes. The overall objective is to determine whether impairments of fibrinolysis underlie subclinical and clinical vascular disease in diabetes in specific populations with and without accelerated microvascular disease.
Blood Coagulation Disorders
|Study Start Date:||September 1996|
|Estimated Study Completion Date:||July 2002|
The results of this project should clarify the extent to which results obtained in experimental animals pertain directly to diabetes in human subjects. The study will also assist in the interpretation of results from clinical studies and from platelet activation experiments.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00005481
|Investigator:||Russell Tracy||University of Vermont|